Pinealon vs Semax

Overview

Pinealon and Semax are both studied in the peptide research space.

Pinealon: A synthetic tripeptide (Glu-Asp-Arg) developed by Russian researcher Vladimir Khavinson as a ‘peptide bioregulator’ claimed to support brain function.

Semax: A synthetic heptapeptide analogue of ACTH(4-7) with a C-terminal Pro-Gly-Pro extension, developed by Russian researchers and approved in Russia since ~1997 for stroke, cognitive impairment, and optic nerve disorders.

Evidence Comparison

Aspect	Pinealon	Semax
Evidence Level	Low	Moderate
Human Studies	2	8
Preclinical Studies	13	24
Total Sources	15	32

Key Differences

Aspect	Pinealon	Semax
Category	Cognitive	Cognitive
Evidence Strength	Low	Moderate
Total Sources	15	32
Human Studies	2	8

Summary

• Pinealon: Low evidence with 15 total sources (2 human)
• Semax: Moderate evidence with 32 total sources (8 human)

---

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.